December 18, 2015
Managerial changes for Parabolic Drugs Limited
Indian pharmaceutical company Parabolic Drugs Limited has made certain changes to its board of directors. Namely, the company announced on…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
December 14, 2015
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion – WSJ
British drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (£3.3 billion).
December 14, 2015
Alvogen to market Natco’s generic Tamiflu capsules until 2017
Alvogen to market Natco’s generic Tamiflu capsules until 2017.
December 10, 2015
Rhizen and Novartis enter deal for PI3K delta gamma inhibitor
Rhizen Pharmaceuticals has entered into an exclusive, worldwide agreement with Novartis for the development and commercialization of Rhizen’s inhaled dual PI3K-delta gamma inhibitor and its closely related compound for various indications.
December 9, 2015
Bristol-Myers wraps up Cardioxyl buy. Dividend increase
Bristol-Myers Squibb Company has completed the previously announced planned acquisition of Cardioxyl Pharmaceuticals, Inc.
December 4, 2015
Genomic Vision partners up with the University-Hospital Institute (IHU) Imagine
Genomic Vision – has signed a strategic partnership with the University-Hospital Institute (IHU) Imagine, the largest European genetic research and care cluster.
December 4, 2015
MaSTherCell will fabricate TxCell’s ASTrIA platform products in Europe
TxCell SA has signed a 5-year agreement with MaSTherCell, a Contract Manufacturing Organization (CMO), based in Belgium.
According to this agreement, MaSTherCell will be the exclusive manufacturer in Europe of all products from TxCell’s ASTrIA platform.
December 4, 2015
India’s Sun Pharmaceutical enters $2.5B US market with its generic version of Gleevec
Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec.
December 2, 2015
Flood in Chennai suspends operations at Natco Pharma API plant (India)
Flood in India’s Chennai suspends operations at Natco Pharma API plant
December 1, 2015
Savy Akers’ production facility in China fully operational
Savy Akers’ 10,000 square foot production facility in Haikou National Hi-Tech Industrial Zone, Hainan province, is now fully operational.